Home/Pipeline/Primatene® MIST (Epinephrine Inhalation Aerosol)

Primatene® MIST (Epinephrine Inhalation Aerosol)

Mild, Intermittent Asthma

Approved/CommercialMarketed

Key Facts

Indication
Mild, Intermittent Asthma
Phase
Approved/Commercial
Status
Marketed
Company

About Amphastar Pharmaceuticals

Amphastar Pharmaceuticals is a vertically integrated biopharmaceutical company with a core mission to develop and deliver high-quality, complex generic and proprietary injectable, inhalation, and intranasal medications. The company has established a strong commercial footprint with products like BAQSIMI®, the leading prescribed glucagon in the U.S., and has been recognized by the FDA for its efforts in alleviating critical drug shortages. Its strategic direction leverages proprietary technological platforms to advance a pipeline of biosimilars and innovative drug delivery systems, aiming to provide accessible treatments across therapeutic areas such as diabetes, respiratory diseases, and anemia.

View full company profile